Raison D'etre

About Difinity


Our focus is to leverage the power of technology in two fields: mobile applications and medical technology. We work to develop various technologies in those fields to innovate and improve the lives of our users. Our team is composed of medical professionals and technology consultants.

Contact Us
or find out more about Our Solutions

Feature

We are currently in the process of engineering and developing the following technologies to bring to market:


logo

A medical device designed to improve hypodermic medication delivery systems with a safer and more robust needle. NeedSafe is the safest needle protective and delivery device to be ever developed.

Provisional patent submitted
Prototype under development
Frequently Asked Questions
...

...
logo

A novel IM needle injection device developed to increase safety, speed, and ease of use in emergent medical situations.

Provisional patent submitted
Prototype under development
Frequently Asked Questions

logo

A connected web and mobile application used in cardiac arrest in the healthcare setting to improve patient outcomes and minimize healthcare provider errors.

Grant submission completed
Seeking alpha development contract
Frequently Asked Questions
...
People

Our Team

David Kim
David Kim, MD, MSc, DAvMed
Co-Founder

David is a recipient of the BC Community Achievement Award for his work in philanthropy, process optimization, and giving back to his community. He joins Difinity with significant experience in leading and executing within the charitable sector as the founder and director of various non-profit organizations. David is currently a resident physician specializing in emergency medicine at the Vancouver General Hospital with sub-specialty interest in Aerospace Medicine and holds a MSc in Aerospace Medicine from King's College London.


Damien Tak
Damien Tak
Co-Founder

Damien has a Bachelor of Science with Distinction from UBC and has most recently worked as a public servant for the Government of Canada. He has worked in leading and founding roles with a number charities and organizations and is always looking to solve problems. Damien wants to empower those around him and has a passion to change the world on a macro scale.


Nicholas Monfries
Nicholas Monfries, MD

Nicholas is an emergency medicine resident physician at the University of British Columbia and is currently completing his subspecialty training in Pediatric Emergency Medicine at the University of Calgary. He is passionate about health system innovation and medical leadership, and has served as a leader and representative on several provincial and national medical organizations.


Trevor Skutezky
Trevor Skutezky, MD, MBA, BASc

Trevor is a resident physician specializing in Emergency Medicine at Vancouver General Hospital. He holds an undergraduate degree in engineering from Queen's University and a Master of Business Administration from Ivey Business School. He brings experience in project management, quality improvement, medical research and first hand healthcare knowledge to the Difinity team.


STAGE

Frequently Asked Questions


Drop us an email if you couldn't find an answer to your question in the following list

When did you start your company?
We started our company in April of 2017.
What have you accomplished so far?
NeedSafe:
Since starting NeedSafe, we have submitted a provisional patent and developed a working prototype.

NeedSwitch:
We have submitted provisional patents and have developed an alpha prototype.

CodeRunner:
We have submitted grant proposals for research funding.
What is your revenue?
Please contact us to inquire about our company revenue.
What is your product roadmap?
NeedSafe:
We are aiming to have a fully functioning device to undergo testing and manufacturing by the end of Q1 2021. We hope to submit and meet FDA and Health Canada Regulations for our device by the end of Q4 2022.

NeedSwitch:
Our goal is to obtain seed funding to further develop and test our prototype device in non-clinical environments with the goal of undergoing clinical testing for FDA and Health Canada approval.

CodeRunner:
We are aiming to have CodeRunner being beta tested in hospitals by the end of Q2 2022.
Who is working fulltime on this?
Damien is commited full time to Difinity Solutions. David commits all of his available time outside of his practice in medicine to this Company.
What are you looking for in an investor?
We are hoping to work with an incubator or investor to support our development, prototyping and marketing endeavours.

Let's Get In Touch

We look forward to hearing from you.